NCI Inc. (NASDAQ:NCIT) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Friday.
According to Zacks, “NCI, Inc. is a leading provider of information technology services and solutions to U.S. federal government agencies. NCI’s award-winning expertise encompasses areas critical to its customers’ mission objectives including enterprise systems management, information assurance, network engineering, and systems development and integration. “
Separately, TheStreet upgraded NCI from a “hold” rating to a “buy” rating in a research report on Wednesday, May 25th. One analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $14.70.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/16/zacks-investment-research-lowers-nci-inc-ncit-to-sell.html
NCI (NASDAQ:NCIT) traded down 0.80% during mid-day trading on Friday, reaching $11.14. The company had a trading volume of 20,229 shares. NCI has a 52 week low of $10.98 and a 52 week high of $17.18. The stock has a 50 day moving average of $12.11 and a 200 day moving average of $13.36. The stock has a market capitalization of $150.43 million, a price-to-earnings ratio of 11.62 and a beta of 1.11.
NCI (NASDAQ:NCIT) last announced its quarterly earnings results on Wednesday, July 27th. The company reported $0.23 earnings per share for the quarter, meeting the consensus estimate of $0.23. The company earned $81.90 million during the quarter, compared to analysts’ expectations of $85.10 million. NCI had a return on equity of 12.39% and a net margin of 4.00%. NCI’s quarterly revenue was down 4.5% on a year-over-year basis. During the same period last year, the business earned $0.22 earnings per share. Analysts anticipate that NCI will post $0.94 earnings per share for the current year.
Hedge funds have recently modified their holdings of the stock. Acadian Asset Management LLC raised its stake in shares of NCI by 1.1% in the first quarter. Acadian Asset Management LLC now owns 346,828 shares of the company’s stock valued at $4,860,000 after buying an additional 3,771 shares during the last quarter. Algert Global LLC raised its stake in shares of NCI by 15.5% in the first quarter. Algert Global LLC now owns 102,147 shares of the company’s stock worth $1,431,000 after buying an additional 13,693 shares in the last quarter. Acrospire Investment Management LLC purchased a new stake in shares of NCI during the first quarter worth about $107,000. UBS Group AG raised its stake in shares of NCI by 3,942.7% in the first quarter. UBS Group AG now owns 19,324 shares of the company’s stock worth $271,000 after buying an additional 18,846 shares in the last quarter. Finally, AXA raised its stake in shares of NCI by 79.2% in the first quarter. AXA now owns 10,769 shares of the company’s stock worth $151,000 after buying an additional 4,758 shares in the last quarter. 37.10% of the stock is currently owned by institutional investors.
NCI Company Profile
NCI, Inc is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration.
Get a free copy of the Zacks research report on NCI (NCIT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for NCI Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for NCI Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.